Renaissance Technologies (RenTech)'s HCA Position Overview
Renaissance Technologies (RenTech) (via Renaissance Technologies LLC) currently holds 18,600 shares of HCA Healthcare, Inc. (HCA) worth $7.25 M, representing 0.01% of the portfolio. First purchased in 2013-Q2, this long-term strategic position has been held for 36 quarters.
Based on 13F filings, Renaissance Technologies (RenTech) has maintained a strategic position in HCA, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2018, adding 714,331 shares. Largest reduction occurred in Q3 2020, reducing 977,400 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies (RenTech)'s HCA Healthcare (HCA) Holding Value Over Time
Track share changes against reported price movement
Quarterly HCA Healthcare (HCA) Trades by Renaissance Technologies (RenTech)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +18,600 | New Buy | 18,600 | $389.89 |
| Q3 2024 | -12,800 | Sold Out | 0 | $0.00 |
| Q2 2024 | +12,800 | New Buy | 12,800 | $321.28 |
| Q4 2023 | -21,300 | Sold Out | 0 | $0.00 |
| Q3 2023 | +21,300 | New Buy | 21,300 | $245.96 |
| Q3 2022 | -323,513 | Sold Out | 0 | $0.00 |
| Q2 2022 | +215,513 | Add 199.55% | 323,513 | $168.06 |
| Q1 2022 | -209,400 | Reduce 65.97% | 108,000 | $250.62 |
| Q4 2021 | +317,400 | New Buy | 317,400 | $256.92 |
| Q3 2020 | -977,400 | Sold Out | 0 | $0.00 |
| Q2 2020 | +427,500 | Add 77.74% | 977,400 | $97.06 |
| Q1 2020 | +392,800 | Add 250.03% | 549,900 | $89.85 |
| Q4 2019 | -32,800 | Reduce 17.27% | 157,100 | $147.81 |
| Q3 2019 | -218,900 | Reduce 53.55% | 189,900 | $120.42 |
| Q2 2019 | -445,000 | Reduce 52.12% | 408,800 | $135.17 |
| Q1 2019 | +647,600 | Add 314.06% | 853,800 | $130.38 |
| Q4 2018 | -261,900 | Reduce 55.95% | 206,200 | $124.45 |
| Q3 2018 | -626,331 | Reduce 57.23% | 468,100 | $139.12 |
| Q2 2018 | +714,331 | Add 187.93% | 1.09 M | $102.60 |
| Q1 2018 | +380,100 | New Buy | 380,100 | $97.00 |
| Q3 2017 | -642,700 | Sold Out | 0 | $0.00 |
| Q2 2017 | +360,600 | Add 127.83% | 642,700 | $87.20 |
| Q1 2017 | +282,100 | New Buy | 282,100 | $88.99 |
| Q4 2016 | -45,100 | Sold Out | 0 | $0.00 |
| Q3 2016 | -529,400 | Reduce 92.15% | 45,100 | $75.63 |
| Q2 2016 | +574,500 | New Buy | 574,500 | $77.01 |
| Q1 2016 | -262,500 | Sold Out | 0 | $0.00 |
| Q4 2015 | -253,900 | Reduce 49.17% | 262,500 | $67.63 |
| Q3 2015 | +452,300 | Add 705.62% | 516,400 | $77.36 |
| Q2 2015 | +64,100 | New Buy | 64,100 | $90.72 |
| Q1 2015 | -382,900 | Sold Out | 0 | $0.00 |
| Q4 2014 | +382,900 | New Buy | 382,900 | $73.39 |
| Q3 2014 | -416,000 | Sold Out | 0 | $0.00 |
| Q2 2014 | +416,000 | New Buy | 416,000 | $56.38 |
| Q3 2013 | -428,900 | Sold Out | 0 | $0.00 |
| Q2 2013 | +428,900 | Add 0.00% | 428,900 | $36.06 |
Renaissance Technologies (RenTech)'s HCA Healthcare Investment FAQs
Renaissance Technologies (RenTech) first purchased HCA Healthcare, Inc. (HCA) in Q2 2013, acquiring 428,900 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies (RenTech) has held HCA Healthcare, Inc. (HCA) for 36 quarters since Q2 2013.
Renaissance Technologies (RenTech)'s largest addition to HCA Healthcare, Inc. (HCA) was in Q2 2018, adding 1,094,431 shares worth $112.29 M.
According to the latest 13F filing for Q2 2026, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC, owns 18,600 shares of HCA Healthcare, Inc. (HCA), valued at approximately $7.25 M.
As of the Q2 2026 filing, HCA Healthcare, Inc. (HCA) represents approximately 0.01% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies (RenTech)'s peak holding in HCA Healthcare, Inc. (HCA) was 1,094,431 shares, as reported at the end of Q2 2018.